Ozempic has been making headlines, and heres whyits a medication with semaglutide, an active ingredient that helps manage type 2 diabetes and supports weight management
For the acarbose group, 49.2% of the subjects were male, the mean age was 58.4 yr, and 66.1% of subjects had diabetic complications
Common Mistakes to Avoid After observing hundreds of people attempt various peptide protocols, certain patterns of failure emerge repeatedly
A1C -1.5% at 12 mg (-1.6% at 9 mg) TRIUMPH-3 obesity with established cardiovascular disease (July 23, 2026) 22.6% weight loss at 12 mg over 80 weeks ADA 86th Scientific Sessions (Jun 6-10, 2026, New Orleans) the full TRIUMPH-1 + TRANSCEND-T2D-1 panel, the most detailed public presentation of the Phase 3 data see our ADA 2026 retatrutide coverage Still expected: TRIUMPH-5 (head-to-head vs tirzepatide, NCT06662383): Phase 3 obesity efficacy comparison